Effect of an ACE inhibitor and an AT1 receptor antagonist on cardiac hypertrophy

Molecular and Cellular Biochemistry

Volumn 248, Issue 1-2, 2003, Pages 197-202

  Shikata, Chihiro ^a   Takeda, Atsushi ^b   Takeda, Nobuakira ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GUNMA PAZ UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; ARB; Cardiac hypertrophy; Fibrosis; SHR

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; COLLAGEN ANTIBODY; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENTOBARBITAL;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; COLLAGEN TYPE I; ECHOCARDIOGRAPHY; FIBROSIS; HEART RATE; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INDANS; MYOCARDIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SYSTOLE; TETRAZOLES;

ANIMALIA;

EID: 0037627916     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024109007392     Document Type: Article

References (26)

1. Jacob R, Ebrecht G, Kammereit A, Medugorac I, Wendt-Gallitelli MF: Myocardial function in different models of cardiac hypertrophy. An attempt at correlating mechanical, biochemical and morphological parameters. Basic Res Cardiol 72: 160-167, 1977
2. Alpert NR, Mulieri LA: Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit. Circ Res 50: 491-500, 1982
3. Simpson P: Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells in an alpha 1 adrenergic response. J Clin Invest 72: 732-738, 1983
4. Xenophontos XP, Watson PA, Chua BHL, Haneda T, Morgan HE: Increased cyclic AMP content accelerates protein synthesis in rat heart. Circ Res 65: 647-656, 1989
5. Zierhut W, Zimmer HG: Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65: 1417-1425, 1989
6. Aceto JF, Baker KM: (Sar 10) angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258: H806-H813, 1990
7. Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259: H610-H618, 1990
8. Takeda N, Nakamura I, Ohkubo T, Iwai T, Tanamura A, Nagano M: Effects of long term treatment with an α1 adrenoceptor blocker on cardiac hypertrophy, contractility, and myosin isoenzymes in spontaneously hypertensive rats. Cardiovasc Res 25: 565-567, 1991
9. Takeda N, Nakamura I, Hatanaka T, Iwai T, Tanamura A, Obara Y, Nagano M: Effects of long-term medication for essential hypertension on cardiac hypertrophy and function. Basic Res Cardiol 86(suppl 3): 197-202, 1991
10. Iwai T, Takeda N, Tuchiya M, Arino T, Tanamura A, Nagano M: Effects of regression of cardiac hypertrophy on myocardial contractility and ventricular myosin isoenzymes. Mol Cell Biochem 118: 99-103, 1992
11. Takeda. N, Iwai T, Tanamura A, Nakamura I, Nagano M: Effects of delapril hydrochloride on the myocardium of spontaneously hypertensive rats. Can J Cardiol 10: 939-943, 1994
12. Takeda N, Tanamura A, Iwai T, Kato M, Noma K, Nagano M: Beneficial effect of ACE inhibitor in congestive heart failure. Mol Cell Biochem 129: 139-143, 1993
13. Brilla CG, Matsubara L, Weber KT: Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosi. Hypertension 28: 269-275, 1996
14. Lijnen P, Petrov V: Antagonism of the renin-angiotensin-aldosterone system and collagen metabolism in cardiac fibroblasts. Meth Find Exp Clin Pharmacol 21: 215-227, 1999
15. Urata H, Kinoshita A, Porez DM, Misono KS, Bumpus FM, Graham RM, Husain A: Cloning of the gene and cDNA for human heart chymase. J Biol Chem 266: 17173-17179, 1991
16. Raya TE, Fonken SJ, Lee RW, Daugherty S, Goldman S, Wang PC, Timmermans PB, Morkin E: Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model for heart failure. Am J Hypertens 4: 334S-340S, 1991
17. Smith JF, van Krimpen C, Schoemaker PG, Cleutjens JP, Daemen MJ: Angiotensin II receptor blockade after myocardial infarction in rats: Effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 20: 772-778, 1992
18. Villarreal FJ, Bahnson T, Kim NN: Human cardiac fibroblasts and receptors for angiotensin II and bradykinin: a potential role for bradykinin in the modulation of cardiac extracellular matrix. Basic Res Cardiol 93(suppl 3): 4-7, 1993
19. Kim NN, Villegas S, Summerour SR, Villarreal FJ: Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J Mol Cell Cardiol 31: 457-466, 1999
20. Lendeckel U, Arndt M, Wrenger S, Nepple K, Huth C, Ansorge S, Klein HU, Goette A: Expression and activity of ectopeptidases in fibrillating human atria. J Mol Cell Cardiol 33: 1273-1281, 2001
21. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96: 509-516, 1997
22. Yamada Y, Goto J, Yokota M: Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 88: 401-407, 1997
23. Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, Ashida T, Sugiyama T, Hada Y, Kuwajima I, Nishinaga M, Akioka H, Nakajima O, Nagai R, Yazaki Y. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 15: 585-591, 2001
24. Maisel A: B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 19: 557-571, 2001
25. Kissling G, Rupp H, Malloy L, Jacob R: Alteration in cardiac oxygen consumption under chronic pressure overload. Significance of the isoenzyme pattern of myosin. Basic Res Cardiol 77: 255-269, 1982
26. Rupp H, Jacob R: Response of blood pressure and cardiac myosin polymorphism to swimming training in the spontaneously hypertensive rat. Can J Physiol Pharmacol 60; 1098-1103, 1982